| http://dbpedia.org/ontology/abstract
|
Ontuxizumab is a humanized rabbit monoclon … Ontuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by and Ludwig Institute for Cancer Research. and Ludwig Institute for Cancer Research.
|
| http://dbpedia.org/ontology/casNumber
|
946415-62-9
|
| http://dbpedia.org/ontology/fdaUniiCode
|
0M2XT000YC
|
| http://dbpedia.org/ontology/wikiPageID
|
39890866
|
| http://dbpedia.org/ontology/wikiPageLength
|
2659
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
981902469
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Tumor_endothelial_marker_1 +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
, http://dbpedia.org/resource/Ludwig_Institute_for_Cancer_Research +
, http://dbpedia.org/resource/Endosialin +
, http://dbpedia.org/resource/Orphan_drug +
, http://dbpedia.org/resource/Morphotek +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
6532
|
| http://dbpedia.org/property/casNumber
|
946415
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/h
|
10050
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/n
|
1726
|
| http://dbpedia.org/property/o
|
2054
|
| http://dbpedia.org/property/s
|
44
|
| http://dbpedia.org/property/source
|
xizu/o
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/Tumor_endothelial_marker_1 +
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
0
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Monoclonals_for_tumors +
, http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antibody +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Ontuxizumab?oldid=981902469&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Ontuxizumab +
|
| owl:sameAs |
http://yago-knowledge.org/resource/Ontuxizumab +
, https://global.dbpedia.org/id/ZPoA +
, http://www.wikidata.org/entity/Q15708295 +
, http://rdf.freebase.com/ns/m.0w7ltml +
, http://dbpedia.org/resource/Ontuxizumab +
|
| rdf:type |
http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Part113809207 +
, http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Antibody115027189 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/MonoclonalAntibody115029781 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/class/yago/Molecule114682133 +
, http://dbpedia.org/class/yago/Unit109465459 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies +
, http://dbpedia.org/class/yago/Macromolecule114944888 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Protein114728724 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
|
| rdfs:comment |
Ontuxizumab is a humanized rabbit monoclon … Ontuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by and Ludwig Institute for Cancer Research. and Ludwig Institute for Cancer Research.
|
| rdfs:label |
Ontuxizumab
|
